RedHill Biopharma
Proprietary Drugs for Gastrointestinal and Infectious Diseases
StartupRedHill Biopharma is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2009. Proprietary Drugs for Gastrointestinal and Infectious Diseases. The company has raised a total of $281.75M across 21 funding rounds, currently at the Public stage. RedHill Biopharma was founded by Dror Ben-Asher. Key investors include Cumberland Pharmaceuticals, Undisclosed Investor(s), HealthCare Royalty Partners , among 14 total investors. The company has 11-50 employees. Core technologies: Biologicals.
With $281.75M in total funding, RedHill Biopharma is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StagePublic
- ProductReleased
- ModelB2B
- Employees11-50
- HQTel Aviv-Yafo
- DistrictCenter District
- Last Round$4M
- Cumberland PharmaceuticalsLead
- Undisclosed Investor(s)
- HealthCare Royalty Partners
14 investors total
Dror Ben-AsherCo-Founder & CEO
188 articles covered by sources including finance.yahoo.com,
www.prnewswire.com,
uk.finance.yahoo.com,
www.pharmaceutical-technology.com,
www.clinicaltrialsarena.com.
What does RedHill Biopharma do?
RedHill Biopharma is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on its promises, to build a company at the forefront of gastrointestinal and infectious diseases management. Its two FDA-approved drugs are promoted in the U.S. by a dedicated and experienced sales team: Talicia and Aemcolo. RedHill has also built an exciting, advanced and largely de-risked R&D pipeline of proprietary late-stage clinical development drug candidates addressing major unmet medical needs.
How much funding has RedHill Biopharma raised?
RedHill Biopharma has raised $281.75M in total funding across 21 rounds. The company is currently at the Public stage. Key investors include Cumberland Pharmaceuticals, Undisclosed Investor(s), HealthCare Royalty Partners .
Who founded RedHill Biopharma?
RedHill Biopharma was founded in 2009 by Dror Ben-Asher (Co-Founder & CEO).
What sector is RedHill Biopharma in?
RedHill Biopharma operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Life Sciences, Pharmaceuticals.
Where is RedHill Biopharma located?
RedHill Biopharma is based in 21 Haarbaa St., 6473921, Tel Aviv, Israel, Center District. The company also has offices abroad.